Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2003 Jun;111(12):1795-803.
doi: 10.1172/JCI18925.

Monogenic hypercholesterolemia: new insights in pathogenesis and treatment

Daniel J Rader  1 , Jonathan Cohen, Helen H Hobbs
Affiliations
Review

Monogenic hypercholesterolemia: new insights in pathogenesis and treatment

Daniel J Rader et al. J Clin Invest. 2003 Jun.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Overview of LDL metabolism in humans. Dietary cholesterol and triglycerides are packaged with apolipoproteins in the enterocytes of the small intestine, secreted into the lymphatic system as chylomicrons (CM). As chylomicrons circulate, the core triglycerides are hydrolyzed by lipoprotein lipase, resulting in the formation of chylomicron remnants (CM Rem), which are rapidly removed by the liver. Dietary cholesterol has four possible fates once it reaches the liver: it can be esterified and stored as cholesteryl esters in hepatocytes; packaged into VLDL particles and secreted into the plasma; secreted directly into the bile; or converted into bile acids and secreted into the bile. VLDL particles secreted into the plasma undergo lipolysis to form VLDL remnants (VLDL Rem). Approximately 50% of VLDL remnants are removed by the liver via the LDLR, and the remainder mature into LDL, the major cholesterol transport particle in the blood. An estimated 70% of circulating LDL is cleared by LDLR in the liver. ABCG5 and ABCG8 are located predominantly in the enterocytes of the duodenum and jejunum, the sites of uptake of dietary sterols, and in hepatocytes, where they participate in sterol trafficking into bile. Mutations in either transporter cause an increase in delivery of dietary sterols to the liver and a decrease in secretion of sterols into the bile. Autosomal recessive hypercholesterolemia (ARH) is a putative adaptor protein that is involved in the mechanics of LDLR-mediated endocytosis. ABCG: ATP-binding cassette, family G.
See this image and copyright information in PMC

References

    1. Heller DA, de Faire U, Pedersen NL, Dahlen G, McClearn GE. Genetic and environmental influences on serum lipid levels in twins. N. Engl. J. Med. 1993;328:1150–1156. - PubMed
    1. Goldstein, J., Hobbs, H., and Brown, M. 2001. Familial hypercholesterolemia. In The metabolic and molecular bases of inherited disease. C. Scriver, A. Beaudet, W. Sly, and D. Valle, editors. McGraw-Hill. New York, New York, USA. 2863–2913.
    1. Sun XM, et al. Familial hypercholesterolemia in China. Identification of mutations in the LDL-receptor gene that result in a receptor-negative phenotype. Arterioscler. Thromb. 1994;14:85–94. - PubMed
    1. Hoeg JM, Feuerstein IM, Tucker EE. Detection and quantitation of calcific atherosclerosis by ultrafast computed tomography in children and young adults with homozygous familial hypercholesterolemia. Arterioscler. Thromb. 1994;14:1066–1074. - PubMed
    1. Hill JS, Hayden MR, Frohlich J, Pritchard PH. Genetic and environmental factors affecting the incidence of coronary artery disease in heterozygous familial hypercholesterolemia. Arterioscler. Thromb. 1991;11:290–297. - PubMed

Publication types

MeSH terms